Eltropag 25mg Tablet
Marketer
Medicamen Biotech Ltd
Salt Composition
Eltrombopag (25mg)
Overview Eltropag 25mg Tablet
Romiplostim 25mg tablets are indicated for the management of low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. This medication also addresses severe aplastic anemia. Romiplostim 25mg is a thrombopoietin receptor agonist, functioning by boosting platelet production. Platelets are crucial for hemostasis. Adhere strictly to your physician's prescribed dosage and duration. It can be taken on an empty stomach and should be swallowed whole; avoid crushing or chewing. Report any allergies to this medication to your doctor. Common adverse reactions include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Consult your doctor if these side effects are problematic; management strategies may be available. Prior to commencing treatment, disclose any existing health issues and all other medications you are using to your doctor. Dosage modification might be necessary for patients with liver impairment.
Uses of Eltropag 25mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; Management of critical aplastic anemia
Major Benefits of Eltropag 25mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eltropag 25mg Tablet on an empty stomach.
Common Side effects of Eltropag 25mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Eltropag 25mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eltropag 25mg Tablet on an empty stomach.
How Eltropag 25mg Tablet works:
Promacta 25mg tablets function as a thrombopoietin receptor activator, prompting increased platelet production within the bloodstream. Elevated platelet levels contribute to hemostasis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of consuming alcohol while taking Eltropag 25mg Tablet is undetermined. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Eltropag 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Eltropag 25mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Eltropag 25mg Tablets, which can induce dizziness and reduced alertness. These side effects could negatively impact your ability to operate a vehicle.
KidneySAFE IF PRESCRIBED
Eltropag 25mg tablets are considered safe for patients with kidney disease; dosage modification is typically unnecessary. Nevertheless, disclosure of kidney disease to your physician is recommended. Routine monitoring of kidney function during treatment is advisable.
LiverCAUTION
Patients with liver impairment should use Eltropag 25mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eltropag 25mg Tablet :
Omit any missed Eltropag 25mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Eltropag 25mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Thrombopoietin receptor activator |


